Sarah Gaskell focuses her practice on the representation of clients in the health care and life sciences industries. She represents hospitals, health systems, physician groups, pharmaceutical and medical device manufacturers, and emerging digital health companies in complex regulatory, transactional, and compliance matters.
Sarah's experience includes guiding clients through direct-to-consumer telemedicine, licensure, patient consent, remote supervision, and corporate practice of medicine issues. She also supports health care clients engaged in M&A and other strategic transactions, including physician practice and hospice acquisitions and private equity investments, and is involved in structuring various management service agreements and other arrangements to provide professional, management, or administrative services.
Sarah also counsels life sciences clients on issues associated with clinical research and the regulation of food, drugs, and medical devices by the Food and Drug Administration (FDA) and provides regulatory and transactional due diligence support in life sciences M&A and other transactions.
Sarah maintains an active pro bono practice, including serving as a guardian ad litem and representing clients in Section 1983 proceedings.
Sarah is a member of the American Health Lawyers Association and the Food and Drug Law Institute.
- The University of Chicago (J.D. 2020; Executive Editor, Chicago Journal of International Law); University of Dayton (B.A. magna cum laude 2009)
- District of Columbia and Massachusetts